TY - JOUR
T1 - Cytidine deamination of retroviral DNA by diverse APOBEC proteins
AU - Bishop, Kate N.
AU - Holmes, Rebecca K.
AU - Sheehy, Ann M.
AU - Davidson, Nicholas O.
AU - Cho, Soo Jin
AU - Malim, Michael H.
N1 - Funding Information:
We thank Reuben Harris, Michael Neuberger, and Scott Morham for stimulating discussions. This work was supported by the United Kingdom Medical Research Council, the Biotechnology and Biological Sciences Research Council, the Royal Society (A.M.S.), and the National Institutes of Health (HL-38180, DK-56260 and DK-52574; N.O.D.). M.H.M. is an Elizabeth Glaser Scientist supported by the Elizabeth Glaser Pediatric AIDS Foundation.
PY - 2004/8/10
Y1 - 2004/8/10
N2 - The human cytidine deaminase APOBEC3G edits both nascent human immunodeficiency virus (HIV) and murine leukemia virus (MLV) reverse transcripts, resulting in loss of infectivity [1-5]. The HIV Vif protein is able to protect both viruses from this innate restriction to infection. Here, we demonstrate that a number of other APOBEC family members from both humans and rodents can mediate anti-HIV effects, through cytidine deamination. Three of these, rat APOBEC1, mouse APOBEC3, and human APOBEC3B, are able to inhibit HIV infectivity even in the presence of Vif. Like APOBEC3G, human APOBEC3F preferentially restricts vif-deficient virus. Indeed, the mutation spectra and expression profile found for APOBEC3F indicate that this enzyme, together with APOBEC3G, accounts for the G to A hypermutation of proviruses described in HIV-infected individuals [6-8]. Surprisingly, although MLV infectivity is acutely reduced by APOBEC3G, no other family member tested here had this effect. It is especially interesting that although both rodent APOBECs markedly diminish wild-type HIV infectivity, MLV is resistant to these proteins. This implies that MLV may have evolved to avoid deamination by mouse APOBEC3. Overall, our findings show that although APOBEC family members are highly related, they exhibit significantly distinct antiviral characteristics that may provide new insights into host-pathogen interactions.
AB - The human cytidine deaminase APOBEC3G edits both nascent human immunodeficiency virus (HIV) and murine leukemia virus (MLV) reverse transcripts, resulting in loss of infectivity [1-5]. The HIV Vif protein is able to protect both viruses from this innate restriction to infection. Here, we demonstrate that a number of other APOBEC family members from both humans and rodents can mediate anti-HIV effects, through cytidine deamination. Three of these, rat APOBEC1, mouse APOBEC3, and human APOBEC3B, are able to inhibit HIV infectivity even in the presence of Vif. Like APOBEC3G, human APOBEC3F preferentially restricts vif-deficient virus. Indeed, the mutation spectra and expression profile found for APOBEC3F indicate that this enzyme, together with APOBEC3G, accounts for the G to A hypermutation of proviruses described in HIV-infected individuals [6-8]. Surprisingly, although MLV infectivity is acutely reduced by APOBEC3G, no other family member tested here had this effect. It is especially interesting that although both rodent APOBECs markedly diminish wild-type HIV infectivity, MLV is resistant to these proteins. This implies that MLV may have evolved to avoid deamination by mouse APOBEC3. Overall, our findings show that although APOBEC family members are highly related, they exhibit significantly distinct antiviral characteristics that may provide new insights into host-pathogen interactions.
UR - http://www.scopus.com/inward/record.url?scp=4143092717&partnerID=8YFLogxK
U2 - 10.1016/j.cub.2004.06.057
DO - 10.1016/j.cub.2004.06.057
M3 - Article
C2 - 15296758
AN - SCOPUS:4143092717
SN - 0960-9822
VL - 14
SP - 1392
EP - 1396
JO - Current Biology
JF - Current Biology
IS - 15
ER -